23andMe's CEO and Cofounder Anne Wojcicki announced that the company agreed to acquire the telemedicine company Lemonaid Health, a move that marks another step in making personalized healthcare a reality and furthers the company's mission to help people access, understand, and benefit from the human genome.

A new 23andMe+ report looks at the genetics around severe acne, a condition that can leave both literal and emotional scars.

Wayne Eskridge CEO of the Fatty Liver Foundation wants to raise awareness about fatty liver disease, and help people make changes toward better health.

This month Comparably included 23andMe on its list of large businesses with the Best Company Work-Life Balance in 2021. The ranking comes from 23andMe employees who submitted anonymous reviews.

After learning she had a BRCA variant that put her at higher risk for breast and ovarian cancer, Jenn took action.

With the world still feeling the effects of the pandemic, the annual meeting of the American Society of Human Genetics will yet again be virtual this year.Last year’s conference showed...

Kipper Fletez-Brant, a computational biologist with our Therapeutics division, thought he’d be a physicist one day.Growing up in Phoenix, Arizona, Kipper escaped the heat reading “hard-sci-fi novels” with mind-bending plots...

California recently enacted a new law to protect consumers’ genetic data privacy, rules 23andMe and Coalition for Genetic Data Protection supported. The new law is similar to protections adopted in Utah and Arizona recently, that 23andMe hopes are adopted nationally.

This week, Anne Wojcicki, 23andMe’s CEO, and Co-Founder signed a letter, along with dozens of CEOs, making a commitment toward advancing equity and inclusion for employees and customers with disabilities. The move deepened the company’s ongoing commitment to diversity, equity, and inclusion through participating in the Disability Equality Index. The index offers a way to gauge the company’s policies and practices for employees and customers with disabilities in the coming years.

Kristy didn't know she had Ashkenazi Jewish ancestry nor what it meant for her health. After using 23andMe she learned she carried a variant in the BRCA1 gene that put her at higher risk for breast and ovarian cancer.